{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg100192z.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>A homologous series of neutral Zn(II) coordination complexes including Zn(PNO)<sub>2</sub> (<bold>1</bold>), Zn(PNO)<sub>2</sub>(3-Br-Py) (<bold>2</bold>), [Zn(PNO)<sub>2</sub>(1,10-phenanthroline)](H<sub>2</sub>O)<sub>5/3</sub> (<bold>3</bold>), and Zn(PNO)<sub>2</sub>(2,2\u2032-Bipy) (<bold>4</bold>), where PNO = deprotonated 2-hydroxypyridine N-oxide, have been synthesized and characterized. Complexes <bold>2</bold>\u2212<bold>4</bold> were prepared by reacting ancillary ligands with complex <bold>1</bold>. Ancillary ligands form coordinate bonds to transition metal center-Zn(II). Their solid-state crystal structures, solubilities, lipophilicities, and association\u2212dissociation properties in aqueous phase have been investigated in the current work. Diffusion-ordered NMR data suggested that association\u2212dissociation properties of mixed-ligand Zn(II) coordination complexes in the aqueous phase are greatly dependent upon the coordination mode of ancillary ligands to Zn(II). By introduction of ancillary ligands, we can rationally modify lipophilicities and solubilities of mixed-ligand Zn(II) coordination complexes on the basis of log <italic toggle=\"yes\">P</italic> of the ancillary ligand. These in vitro data highlighted the approach of forming mixed-ligand coordination species in fine-tuning physical-chemical properties of Zn(II) species for medicinal applications.</p>", "clean_text": "A homologous series of neutral Zn(II) coordination complexes including Zn(PNO)2 (1), Zn(PNO)2(3-Br-Py) (2), [Zn(PNO)2(1,10-phenanthroline)](H2O)5/3 (3), and Zn(PNO)2(2,2'-Bipy) (4), where PNO = deprotonated 2-hydroxypyridine N-oxide, have been synthesized and characterized. Complexes 2-4 were prepared by reacting ancillary ligands with complex 1. Ancillary ligands form coordinate bonds to transition metal center-Zn(II). Their solid-state crystal structures, solubilities, lipophilicities, and association-dissociation properties in aqueous phase have been investigated in the current work. Diffusion-ordered NMR data suggested that association-dissociation properties of mixed-ligand Zn(II) coordination complexes in the aqueous phase are greatly dependent upon the coordination mode of ancillary ligands to Zn(II). By introduction of ancillary ligands, we can rationally modify lipophilicities and solubilities of mixed-ligand Zn(II) coordination complexes on the basis of log P of the ancillary ligand. These in vitro data highlighted the approach of forming mixed-ligand coordination species in fine-tuning physical-chemical properties of Zn(II) species for medicinal applications.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>Lipophilicities and solubilities of Zn(II) coordination complexes can be rationally modified by introduction of ancillary ligands. It was observed that association\u2212dissociation properties of mixed-ligand Zn(II) coordination complexes in the aqueous phase are dependent upon the coordination mode of the ancillary ligand, as confirmed by DOSY experiments.</p>", "clean_text": "Lipophilicities and solubilities of Zn(II) coordination complexes can be rationally modified by introduction of ancillary ligands. It was observed that association-dissociation properties of mixed-ligand Zn(II) coordination complexes in the aqueous phase are dependent upon the coordination mode of the ancillary ligand, as confirmed by DOSY experiments.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Successful clinical uses of transition metal coordination complexes such as platinum-containing <italic toggle=\"yes\">cis</italic>-platin, gold-containing auranofin, and zinc-containing polaprezinc have inspired chemists to develop novel transition metal (TM) coordination species as drug candidates. In recent years, a large number of TM coordination species for medicinal applications have been synthesized and evaluated in vivo showing promising therapeutic effects. In particular, synthesis of novel TM coordination species utilizing various transition metals ions and new organic ligands represents a major activity in this field. Alternatively, our group has been interested in rationally tuning physical\u2212chemical properties (e.g., lipophilicity, solubility) of existing transition metal coordination species of medicinal interest by introducing ancillary ligands (AL) through coordinate bonds.\n</p>", "clean_text": "Introduction\n\nSuccessful clinical uses of transition metal coordination complexes such as platinum-containing cis-platin, gold-containing auranofin, and zinc-containing polaprezinc have inspired chemists to develop novel transition metal (TM) coordination species as drug candidates. In recent years, a large number of TM coordination species for medicinal applications have been synthesized and evaluated in vivo showing promising therapeutic effects. In particular, synthesis of novel TM coordination species utilizing various transition metals ions and new organic ligands represents a major activity in this field. Alternatively, our group has been interested in rationally tuning physical-chemical properties (e.g., lipophilicity, solubility) of existing transition metal coordination species of medicinal interest by introducing ancillary ligands (AL) through coordinate bonds. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>The lipophilicity and solubility of a drug are both key parameters that influence its absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Furthermore, the lipophilicity and solubility of a drug are also essential factors to be taken into account at the formulation development stage. Octanol/water partition coefficient <italic toggle=\"yes\">P</italic> is commonly used as the suitable estimate of lipophilicity. For a drug with low log <italic toggle=\"yes\">P</italic>, low lipophilicity often tends to prevent the drug from reaching its target. In contrast, for a drug with relatively high log <italic toggle=\"yes\">P</italic> values, the high lipophilic nature of the drug molecule often results in loss of water solubility leading to low bioavailability. Therefore, a range of log <italic toggle=\"yes\">P</italic> generally exists for a certain class of drugs to obtain optimal medicinal efficacy; for example, Hansch and Clayton suggested the optimal log <italic toggle=\"yes\">P</italic> value is around 2 for a central nervous system (CNS) drug\u2019s passive penetration into the brain. Therefore, we aim to modify lipophilicities of coordination species of medicinal interest in a rational way.</p>", "clean_text": "The lipophilicity and solubility of a drug are both key parameters that influence its absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. Furthermore, the lipophilicity and solubility of a drug are also essential factors to be taken into account at the formulation development stage. Octanol/water partition coefficient P is commonly used as the suitable estimate of lipophilicity. For a drug with low log P, low lipophilicity often tends to prevent the drug from reaching its target. In contrast, for a drug with relatively high log P values, the high lipophilic nature of the drug molecule often results in loss of water solubility leading to low bioavailability. Therefore, a range of log P generally exists for a certain class of drugs to obtain optimal medicinal efficacy; for example, Hansch and Clayton suggested the optimal log P value is around 2 for a central nervous system (CNS) drug's passive penetration into the brain. Therefore, we aim to modify lipophilicities of coordination species of medicinal interest in a rational way.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>Lipophilicities and solubilities of Zn(II) coordination complexes were modified by introduction of ancillary ligands (AL) to form mixed-ligand coordination complexes in the current work. Strategies using ancillary ligands to modify lipophilicities of Cu(II) coordination species have recently been reported by our group. As Zn(II) has weaker affinities to organic ligands than Cu(II), we were interested in investigating whether the approach of using ancillary ligands can be applied to other transition metal coordination systems such as Zn(II) as well.</p>", "clean_text": "Lipophilicities and solubilities of Zn(II) coordination complexes were modified by introduction of ancillary ligands (AL) to form mixed-ligand coordination complexes in the current work. Strategies using ancillary ligands to modify lipophilicities of Cu(II) coordination species have recently been reported by our group. As Zn(II) has weaker affinities to organic ligands than Cu(II), we were interested in investigating whether the approach of using ancillary ligands can be applied to other transition metal coordination systems such as Zn(II) as well.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>In this work, Zn(PNO)<sub>2</sub> was chosen as the starting material, where HPNO stands for 2-hydroxypyridine N-oxide. The starting material Zn(PNO)<sub>2</sub> and its analogues are known to be a class of compounds with insulin-mimetic effects. It is also worth noting that HPNO has been well-known as a metal chelator having biological interest and a nuclear waste repository of environmental importance. A few transition metal complexes with HPNO as a ligand have been reported for their interesting chemical and biological properties. Three ancillary ligands including 3-bromo-pyridine (3-Br-Py), 1,10-phenanthroline, and 2,2\u2032-bipyridine (2,2\u2032-Bipy) reacted with Zn(PNO)<sub>2</sub> to form neutral mixed-ligand Zn(II) coordination species. As a follow-up study, this work further explored the effect of coordination modes of ancillary ligands (monodentate and bidentate) upon association\u2212dissociation properties of mixed-ligand coordination species in aqueous phase utilizing diffusion-ordered NMR spectroscopy (DOSY) technique. Solubilities and lipophilicities of mixed-ligand Zn(II) coordination species were also analyzed in detail in this study.</p>", "clean_text": "In this work, Zn(PNO)2 was chosen as the starting material, where HPNO stands for 2-hydroxypyridine N-oxide. The starting material Zn(PNO)2 and its analogues are known to be a class of compounds with insulin-mimetic effects. It is also worth noting that HPNO has been well-known as a metal chelator having biological interest and a nuclear waste repository of environmental importance. A few transition metal complexes with HPNO as a ligand have been reported for their interesting chemical and biological properties. Three ancillary ligands including 3-bromo-pyridine (3-Br-Py), 1,10-phenanthroline, and 2,2'-bipyridine (2,2'-Bipy) reacted with Zn(PNO)2 to form neutral mixed-ligand Zn(II) coordination species. As a follow-up study, this work further explored the effect of coordination modes of ancillary ligands (monodentate and bidentate) upon association-dissociation properties of mixed-ligand coordination species in aqueous phase utilizing diffusion-ordered NMR spectroscopy (DOSY) technique. Solubilities and lipophilicities of mixed-ligand Zn(II) coordination species were also analyzed in detail in this study.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<title>Experimental Section</title><title>Materials and Methods</title><p>1-Octanol (ACS reagent, \u226599%) were ordered from Sigma-Aldrich Co. Deionized water with resistivity up to 18.3 M\u03a9/cm were prepared by a NANOpure Ultrapure Water System. All other materials were obtained from Sigma-Aldrich Co. and used as received.</p>", "clean_text": "Experimental Section\n\nMaterials and Methods\n\n1-Octanol (ACS reagent, \u226599%) were ordered from Sigma-Aldrich Co. Deionized water with resistivity up to 18.3 M\u03a9/cm were prepared by a NANOpure Ultrapure Water System. All other materials were obtained from Sigma-Aldrich Co. and used as received.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<p>Single crystal X-ray diffraction data were collected on a BRUKER SMART-APEX CCD diffractometer using MoK\u03b1 radiation (\u03bb = 0.71073 \u00c5). The single crystal structures were solved by direct methods and refined by full matrix least-squares methods with the SHELXTL-97 package. Hydrogen atoms attached to C atoms were placed at ideal positions. Single crystal molecular graphics were generated using Accelrys MS Modeling v4.0.</p>", "clean_text": "Single crystal X-ray diffraction data were collected on a BRUKER SMART-APEX CCD diffractometer using MoK\u03b1 radiation (\u03bb = 0.71073 \u00c5). The single crystal structures were solved by direct methods and refined by full matrix least-squares methods with the SHELXTL-97 package. Hydrogen atoms attached to C atoms were placed at ideal positions. Single crystal molecular graphics were generated using Accelrys MS Modeling v4.0.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "text", "classification": "error", "content": "<p>UV\u2212vis spectra were recorded on a HP 8452A DIODE ARRAY UV\u2212vis spectrometer. NMR spectra were obtained on a Bruker Avance 400 MHz spectrometer equipped with a <italic toggle=\"yes\">z</italic>-axis gradient amplifier and a probe with a <italic toggle=\"yes\">z</italic>-axis gradient coil (maximum gradient strength was 0.214 T/m). NMR tubes with a 5-mm internal diameter were used. The chemical shift of water (D<sub>2</sub>O) signal observed for <sup>1</sup>H NMR is 4.8. Complete <sup>1</sup>H chemical shift assignments for complexes <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> are available in . The diffusion NMR experiments (DOSY) in D<sub>2</sub>O were acquired at 298 K using bipolar longitudinal eddy current delay with gradients. Diffusion coefficients were measured by incrementing the amplitude of the field gradient pulse. The bipolar gradient duration and the diffusion time were optimized to 600\u22121050 \u03bcs and 200\u2212300 ms, respectively. Gradient recovery delays were 500 \u03bcs. Individual rows of the quasi-2-D diffusion databases were phased and baseline corrected.</p>", "clean_text": "UV-vis spectra were recorded on a HP 8452A DIODE ARRAY UV-vis spectrometer. NMR spectra were obtained on a Bruker Avance 400 MHz spectrometer equipped with a z-axis gradient amplifier and a probe with a z-axis gradient coil (maximum gradient strength was 0.214 T/m). NMR tubes with a 5-mm internal diameter were used. The chemical shift of water (D2O) signal observed for 1H NMR is 4.8. Complete 1H chemical shift assignments for complexes 2, 3, and 4 are available in . The diffusion NMR experiments (DOSY) in D2O were acquired at 298 K using bipolar longitudinal eddy current delay with gradients. Diffusion coefficients were measured by incrementing the amplitude of the field gradient pulse. The bipolar gradient duration and the diffusion time were optimized to 600-1050 \u03bcs and 200-300 ms, respectively. Gradient recovery delays were 500 \u03bcs. Individual rows of the quasi-2-D diffusion databases were phased and baseline corrected.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 10, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of the Complexes</title><p>Zn(PNO)<sub>2</sub> (<bold>1</bold>) was synthesized following a reported procedure, and the colorless crystal was formed. Yield: 3.97 g, 83% (100% theoretical yield is 4.78 g).</p><p>Zn(PNO)<sub>2</sub>(3-Br-Py) (<bold>2</bold>) was prepared by adding anhydrous 3-Br-Py to 0.50 g of Zn(PNO)<sub>2</sub> until the solid was merged by 3-Br-Py in a 4-mL Dram glass vial. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the white to off-white solid was collected. Yield: 0.71 g, 92%. The solid was not suitable for single crystal X-ray diffractions. The composition of complex (<bold>2</bold>) was obtained from <sup>1</sup>H NMR, \u03b4 (D<sub>2</sub>O, 400 MHz): 8.67 (1H, s), 8.49 (1H, d, <italic toggle=\"yes\">J</italic> = 4.6 Hz), 8.08 (1H, d, <italic toggle=\"yes\">J</italic> = 8.2 Hz),7.98 (2H, d, <italic toggle=\"yes\">J</italic> = 5.7 Hz) 7.49 (2H, t, <italic toggle=\"yes\">J</italic> = 6.0 Hz), 7.41 (1H, dd, <italic toggle=\"yes\">J</italic> = 4.8 Hz, <italic toggle=\"yes\">J</italic> = 7.0 Hz), 6.80 (2H, d, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 6.67 (2H, t, <italic toggle=\"yes\">J</italic> = 6.1 Hz).</p>", "clean_text": "Synthesis of the Complexes\n\nZn(PNO)2 (1) was synthesized following a reported procedure, and the colorless crystal was formed. Yield: 3.97 g, 83% (100% theoretical yield is 4.78 g).\n\nZn(PNO)2(3-Br-Py) (2) was prepared by adding anhydrous 3-Br-Py to 0.50 g of Zn(PNO)2 until the solid was merged by 3-Br-Py in a 4-mL Dram glass vial. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the white to off-white solid was collected. Yield: 0.71 g, 92%. The solid was not suitable for single crystal X-ray diffractions. The composition of complex (2) was obtained from 1H NMR, \u03b4 (D2O, 400 MHz): 8.67 (1H, s), 8.49 (1H, d, J = 4.6 Hz), 8.08 (1H, d, J = 8.2 Hz),7.98 (2H, d, J = 5.7 Hz) 7.49 (2H, t, J = 6.0 Hz), 7.41 (1H, dd, J = 4.8 Hz, J = 7.0 Hz), 6.80 (2H, d, J = 8.4 Hz), 6.67 (2H, t, J = 6.1 Hz).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 11, "type": "text", "classification": ["synthesis condition"], "content": "<p>[Zn(PNO)<sub>2</sub>(1,10-Phenanthroline)](H<sub>2</sub>O)<sub>5/3</sub> (<bold>3</bold>) was prepared by mixing 20 mL of Zn(PNO)<sub>2</sub> water solution (5.71 g/L) and 4 mL of 1,10-phenanthroline EtOH solution (18.0 g/L) in a flask. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the colorless crystal was formed. Yield: 0.10 g, 51%. The composition of complex (<bold>3</bold>) was also confirmed by <sup>1</sup>H NMR, \u03b4 (D<sub>2</sub>O, 400 MHz): 8.98 (2H, d, <italic toggle=\"yes\">J</italic> = 4.3 Hz), 8.66 (2H, d, <italic toggle=\"yes\">J</italic> = 8.0 Hz), 8.07 (2H, s), 7.96 (2H, d, <italic toggle=\"yes\">J</italic> = 6.2 Hz), 7.90 (2H, t, <italic toggle=\"yes\">J</italic> = 2.1 Hz), 7.37 (2H, t, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 6.68 (2H, d, <italic toggle=\"yes\">J</italic> = 8.6 Hz), 6.53 (2H, t, <italic toggle=\"yes\">J</italic> = 7.0 Hz).</p>", "clean_text": "[Zn(PNO)2(1,10-Phenanthroline)](H2O)5/3 (3) was prepared by mixing 20 mL of Zn(PNO)2 water solution (5.71 g/L) and 4 mL of 1,10-phenanthroline EtOH solution (18.0 g/L) in a flask. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the colorless crystal was formed. Yield: 0.10 g, 51%. The composition of complex (3) was also confirmed by 1H NMR, \u03b4 (D2O, 400 MHz): 8.98 (2H, d, J = 4.3 Hz), 8.66 (2H, d, J = 8.0 Hz), 8.07 (2H, s), 7.96 (2H, d, J = 6.2 Hz), 7.90 (2H, t, J = 2.1 Hz), 7.37 (2H, t, J = 7.7 Hz), 6.68 (2H, d, J = 8.6 Hz), 6.53 (2H, t, J = 7.0 Hz).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 12, "type": "text", "classification": ["synthesis condition"], "content": "<p>Zn(PNO)<sub>2</sub>(2,2\u2032-Bipy) (<bold>4</bold>) was synthesized under hydrothermal conditions: 15 mL of Zn(PNO)<sub>2</sub> water solution (5.71 g/L) was placed into a 20 mL Teflon autoclave, and 0.3 mmol of 2,2-Bipy was then transferred into the autoclave as well. The Teflon autoclave was then sealed and placed in an oven with holding the temperature at 130 \u00b0C overnight. And the oven was turned off to allow the Teflon bomb to cool down gradually. The colorless crystal was formed. Yield: 0.065 g, 49%. The composition of complex (<bold>4</bold>) was also confirmed by <sup>1</sup>H NMR, \u03b4 (D<sub>2</sub>O, 400 MHz): 8.59 (2H, s), 8.37 (2H, d, <italic toggle=\"yes\">J</italic> = 8.0 Hz), 8.12 (2H, d, <italic toggle=\"yes\">J</italic> = 7.8 Hz), 7.82 (2H, d, <italic toggle=\"yes\">J</italic> = 6.2 Hz), 7.58 (2H, t, <italic toggle=\"yes\">J</italic> = 5.9 Hz), 7.36 (2H, t, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 6.68 (2H, d, <italic toggle=\"yes\">J</italic> = 7.9 Hz), 6.53 (2H, t, <italic toggle=\"yes\">J</italic> = 6.7 Hz).</p>", "clean_text": "Zn(PNO)2(2,2'-Bipy) (4) was synthesized under hydrothermal conditions: 15 mL of Zn(PNO)2 water solution (5.71 g/L) was placed into a 20 mL Teflon autoclave, and 0.3 mmol of 2,2-Bipy was then transferred into the autoclave as well. The Teflon autoclave was then sealed and placed in an oven with holding the temperature at 130 \u00b0C overnight. And the oven was turned off to allow the Teflon bomb to cool down gradually. The colorless crystal was formed. Yield: 0.065 g, 49%. The composition of complex (4) was also confirmed by 1H NMR, \u03b4 (D2O, 400 MHz): 8.59 (2H, s), 8.37 (2H, d, J = 8.0 Hz), 8.12 (2H, d, J = 7.8 Hz), 7.82 (2H, d, J = 6.2 Hz), 7.58 (2H, t, J = 5.9 Hz), 7.36 (2H, t, J = 7.7 Hz), 6.68 (2H, d, J = 7.9 Hz), 6.53 (2H, t, J = 6.7 Hz).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<title>Measurement of Partition Coefficient (Lipophilicity)</title><p>Partition coefficients of complexes were determined in 1-octanol/water system. 1-Octanol and water were mutually saturated before use. The octanol saturated water (ow) layer was used to prepare the stock solution, generally 25 mL of which was stirred vigorously, in triplicate, with 50 mL of water saturated octanol (wo) at 25 \u00b0C overnight. The organic layer was collected and centrifuged at 7000 rpm for 20 min to remove trace amounts of water. The organic layer was analyzed by UV. The partition coefficient was determined from eq .<disp-formula id=\"eq1\">\n<label>1</label>\n<mml:math altimg=\"cg-2010-00192z_m001.gif\" display=\"block\" overflow=\"scroll\">\n<mml:mi>P</mml:mi>\n<mml:mo>=</mml:mo>\n<mml:mfrac>\n<mml:mrow>\n<mml:msub>\n<mml:mrow>\n<mml:mi>C</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">w</mml:mi>\n<mml:mi mathvariant=\"normal\">o</mml:mi>\n</mml:mrow>\n</mml:msub>\n</mml:mrow>\n<mml:mrow>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:mi mathvariant=\"italic\">m</mml:mi>\n<mml:mo>\u2212</mml:mo>\n<mml:msub>\n<mml:mrow>\n<mml:mi>C</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">w</mml:mi>\n<mml:mi mathvariant=\"normal\">o</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:msub>\n<mml:mrow>\n<mml:mi>V</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">w</mml:mi>\n<mml:mi mathvariant=\"normal\">o</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">)</mml:mo>\n<mml:mtext>/</mml:mtext>\n<mml:msub>\n<mml:mrow>\n<mml:mi>V</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">o</mml:mi>\n<mml:mi mathvariant=\"normal\">w</mml:mi>\n</mml:mrow>\n</mml:msub>\n</mml:mrow>\n</mml:mfrac>\n</mml:math>\n</disp-formula>where <italic toggle=\"yes\">m</italic> represents the total mass of the sample; <italic toggle=\"yes\">C</italic>\n<sub>wo</sub> represents equilibrium solute concentrations of the octanol phase; <italic toggle=\"yes\">V</italic>\n<sub>ow</sub> and <italic toggle=\"yes\">V</italic>\n<sub>wo</sub> represent the volume of aqueous and octanol phases, respectively.</p>", "clean_text": "Measurement of Partition Coefficient (Lipophilicity)\n\nPartition coefficients of complexes were determined in 1-octanol/water system. 1-Octanol and water were mutually saturated before use. The octanol saturated water (ow) layer was used to prepare the stock solution, generally 25 mL of which was stirred vigorously, in triplicate, with 50 mL of water saturated octanol (wo) at 25 \u00b0C overnight. The organic layer was collected and centrifuged at 7000 rpm for 20 min to remove trace amounts of water. The organic layer was analyzed by UV. The partition coefficient was determined from eq . 1  P =     C   w o     ( m -   C   w o     V   w o   ) /   V   o w      where m represents the total mass of the sample; C wo represents equilibrium solute concentrations of the octanol phase; V ow and V wo represent the volume of aqueous and octanol phases, respectively.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<title>Measurement of Solubility</title><p>Solubilities were determined at 25 \u00b0C in water (<italic toggle=\"yes\">S</italic>\n<sub>w</sub>), octanol saturated water (<italic toggle=\"yes\">S</italic>\n<sub>ow</sub>), and water saturated octanol (<italic toggle=\"yes\">S</italic>\n<sub>wo</sub>). An excess of the sample was added to 15 mL of each solvent and stirred vigorously at 25 \u00b0C for 8 h. This was then ported immediately into centrifuge tubes, and centrifuged at 7000 rpm for 20 min. The supernatant was collected. The supernatant samples after appropriate dilutions with respective solvent were analyzed by UV spectroscopy using a standard plot of solute in the same medium.</p>", "clean_text": "Measurement of Solubility\n\nSolubilities were determined at 25 \u00b0C in water (S w), octanol saturated water (S ow), and water saturated octanol (S wo). An excess of the sample was added to 15 mL of each solvent and stirred vigorously at 25 \u00b0C for 8 h. This was then ported immediately into centrifuge tubes, and centrifuged at 7000 rpm for 20 min. The supernatant was collected. The supernatant samples after appropriate dilutions with respective solvent were analyzed by UV spectroscopy using a standard plot of solute in the same medium.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Description of Crystal Structures</title><p>Crystal data and structure refinement details for complexes <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> are summarized in Table .</p><title>Crystal Structure of Zn(PNO)<sub>2</sub> (<bold>1</bold>)</title><p>Zn(PNO)<sub>2</sub> crystallized in the triclinic <italic toggle=\"yes\">P</italic>1\u0305 space group. The molecular structure of <bold>1</bold> at the solid state is shown in Figure . The coordination geometry around Zn(II) is a distorted octahedron. Zn(II) is six-coordinated by two hydroxyl oxygen atoms and four N-oxide oxygen atoms. Zn(PNO)<sub>2</sub> could be regarded as a molecular building unit in the crystal structure. Around the Zn(II) center, two deprotonated HPNO molecules coordinate to Zn(II) as a bidentate ligand which occupy four coordination sites in total. And two other N-oxide oxygen atoms from neighboring molecular building units also participate in the coordination to Zn(II) to complete the coordination geometry. As such, Zn(PNO)<sub>2</sub> building units propagate along the crystallographic <italic toggle=\"yes\">a</italic> axis to form one-dimensional chains, Figure .</p>", "clean_text": "Results and Discussion\n\nDescription of Crystal Structures\n\nCrystal data and structure refinement details for complexes 1, 3, and 4 are summarized in Table .\n\nCrystal Structure of Zn(PNO)2 (1)\n\nZn(PNO)2 crystallized in the triclinic P1\u0305 space group. The molecular structure of 1 at the solid state is shown in Figure . The coordination geometry around Zn(II) is a distorted octahedron. Zn(II) is six-coordinated by two hydroxyl oxygen atoms and four N-oxide oxygen atoms. Zn(PNO)2 could be regarded as a molecular building unit in the crystal structure. Around the Zn(II) center, two deprotonated HPNO molecules coordinate to Zn(II) as a bidentate ligand which occupy four coordination sites in total. And two other N-oxide oxygen atoms from neighboring molecular building units also participate in the coordination to Zn(II) to complete the coordination geometry. As such, Zn(PNO)2 building units propagate along the crystallographic a axis to form one-dimensional chains, Figure .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 16, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Coordination geometry of complex <bold>1</bold>.</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Coordination geometry of complex 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>One-dimensional chain structure in complex <bold>1</bold>.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  One-dimensional chain structure in complex 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data and Structure Refinement Details for <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry>compound</oasis:entry>\n<oasis:entry>complex <bold>1</bold>\n</oasis:entry>\n<oasis:entry>complex <bold>3</bold>\n</oasis:entry>\n<oasis:entry>complex <bold>4</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>10</sub>H<sub>8</sub>N<sub>2</sub>O<sub>4</sub>Zn</oasis:entry>\n<oasis:entry>C<sub>66</sub>H<sub>58</sub>N<sub>12</sub>O<sub>17</sub>Zn<sub>3</sub>\n</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>Zn</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>color</oasis:entry>\n<oasis:entry>colorless</oasis:entry>\n<oasis:entry>colorless</oasis:entry>\n<oasis:entry>colorless</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size (mm)</oasis:entry>\n<oasis:entry>0.90 \u00d7 0.85 \u00d7 0.80</oasis:entry>\n<oasis:entry>0.50 \u00d7 0.20 \u00d7 0.10</oasis:entry>\n<oasis:entry>0.50 \u00d7 0.40 \u00d7 0.40</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>formula weight</oasis:entry>\n<oasis:entry>285.55</oasis:entry>\n<oasis:entry>1487.35</oasis:entry>\n<oasis:entry>441.74</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>temperature (K)</oasis:entry>\n<oasis:entry>90(2)</oasis:entry>\n<oasis:entry>90(2)</oasis:entry>\n<oasis:entry>90(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>wavelength (\u00c5)</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal system, space group</oasis:entry>\n<oasis:entry>triclinic, <italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>triclinic, <italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>orthorhombic, <italic toggle=\"yes\">Pbca</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>6.343(9)</oasis:entry>\n<oasis:entry>9.1837(18)</oasis:entry>\n<oasis:entry>9.5912(19)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>8.856(13)</oasis:entry>\n<oasis:entry>18.715(4)</oasis:entry>\n<oasis:entry>15.983(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.599(14)</oasis:entry>\n<oasis:entry>19.053(4)</oasis:entry>\n<oasis:entry>24.334(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (\u00b0)</oasis:entry>\n<oasis:entry>81.49(2)</oasis:entry>\n<oasis:entry>105.34(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (\u00b0)</oasis:entry>\n<oasis:entry>79.87(2)</oasis:entry>\n<oasis:entry>94.59(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (\u00b0)</oasis:entry>\n<oasis:entry>81.30(2)</oasis:entry>\n<oasis:entry>98.05(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>volume (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>520.7(13)</oasis:entry>\n<oasis:entry>3103.3(11)</oasis:entry>\n<oasis:entry>3730.4(13)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Z<italic toggle=\"yes\">,</italic> calculated density (mg/cm<sup>3</sup>)</oasis:entry>\n<oasis:entry>2, 1.821</oasis:entry>\n<oasis:entry>2, 1.592</oasis:entry>\n<oasis:entry>8, 1.573</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>absorption coefficient (mm<sup>\u22121</sup>)</oasis:entry>\n<oasis:entry>2.362</oasis:entry>\n<oasis:entry>1.235</oasis:entry>\n<oasis:entry>1.353</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">F</italic>(000)</oasis:entry>\n<oasis:entry>288</oasis:entry>\n<oasis:entry>1528</oasis:entry>\n<oasis:entry>1808</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>reflections collected/unique</oasis:entry>\n<oasis:entry>3331/1949 [R(int) = 0.1570]</oasis:entry>\n<oasis:entry>10726/9733 [R(int) = 0.0702]</oasis:entry>\n<oasis:entry>18301/3474 [R(int) = 0.0290]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>completeness to \u03b8 = <italic toggle=\"yes\">x</italic>\u00b0 (%)</oasis:entry>\n<oasis:entry>95.1 (theta = 26.02)</oasis:entry>\n<oasis:entry>89.1 (theta = 25.00)</oasis:entry>\n<oasis:entry>100.0 (theta = 25.50)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>max and min transmission</oasis:entry>\n<oasis:entry>0.2538 and 0.2250</oasis:entry>\n<oasis:entry>0.8865 and 0.5772</oasis:entry>\n<oasis:entry>0.6137 and 0.5511</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>refinement method</oasis:entry>\n<oasis:entry>full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>goodness-of-fit on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.078</oasis:entry>\n<oasis:entry>1.036</oasis:entry>\n<oasis:entry>1.053</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>final <italic toggle=\"yes\">R</italic> indices [<italic toggle=\"yes\">I</italic> &gt; 2\u03c3(I)]</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0698, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.1883</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0791, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.1845</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0270, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.0735</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic> indices (all data)</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0795, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.2008</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.1210, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.2014</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0308, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.0756</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>CCDC number</oasis:entry>\n<oasis:entry>749773</oasis:entry>\n<oasis:entry>749774</oasis:entry>\n<oasis:entry>749775</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<title>Crystal Structure of [Zn(PNO)<sub>2</sub>(1,10-Phenanthroline)](H<sub>2</sub>O)<sub>5/3</sub> (<bold>3</bold>)</title><p>Single crystal X-ray determination shows that <bold>3</bold> is a discrete complex at the solid state, in which Zn(II) centers are six-coordinated. Zn(PNO)<sub>2</sub>(1,10-phenanthroline) crystallized in the triclinic <italic toggle=\"yes\">P</italic>1\u0305 space group with guest water molecules in the lattice. As shown in Figure , the coordination geometry around Zn(II) is also a distorted octahedron. Two deprotonated HPNO molecules and one 1,10-phenanthroline all act as bidentate ligands around Zn(II) occupying six coordination sites. \u03c0\u2212\u03c0 interactions are observed between 1,10-phenanthroline molecules in the crystal structure, Figure . Discrete Zn(PNO)<sub>2</sub>(1,10-phenanthroline) building units grow along the crystallographic <italic toggle=\"yes\">a</italic> axis with the aid of \u03c0\u2212\u03c0 interactions. Interplanar separation between parallel 1,10-phenanthroline ligands has the average calculated distance of 3.34 \u00c5, which is sufficiently close for weak \u03c0\u2212\u03c0 interactions.\n</p>", "clean_text": "Crystal Structure of [Zn(PNO)2(1,10-Phenanthroline)](H2O)5/3 (3)\n\nSingle crystal X-ray determination shows that 3 is a discrete complex at the solid state, in which Zn(II) centers are six-coordinated. Zn(PNO)2(1,10-phenanthroline) crystallized in the triclinic P1\u0305 space group with guest water molecules in the lattice. As shown in Figure , the coordination geometry around Zn(II) is also a distorted octahedron. Two deprotonated HPNO molecules and one 1,10-phenanthroline all act as bidentate ligands around Zn(II) occupying six coordination sites. \u03c0-\u03c0 interactions are observed between 1,10-phenanthroline molecules in the crystal structure, Figure . Discrete Zn(PNO)2(1,10-phenanthroline) building units grow along the crystallographic a axis with the aid of \u03c0-\u03c0 interactions. Interplanar separation between parallel 1,10-phenanthroline ligands has the average calculated distance of 3.34 \u00c5, which is sufficiently close for weak \u03c0-\u03c0 interactions. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Coordination geometry of complex <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Coordination geometry of complex 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Schematic illustration of \u03c0\u2212\u03c0 interactions in complex <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  Schematic illustration of \u03c0-\u03c0 interactions in complex 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "text", "classification": "error", "content": "<title>Crystal Structure of Zn(PNO)<sub>2</sub>(2,2\u2032-Bipy) (<bold>4</bold>)</title><p>This complex gives a structure which is similar to that of complex <bold>3</bold>, Figure . Zn(PNO)<sub>2</sub>(2,2\u2032-Bipy) crystallized in the orthorhombic <italic toggle=\"yes\">Pbca</italic> space group. The coordination geometry around Zn(II) is also a distorted octahedron. Zn(II) is coordinated by two hydroxyl oxygen atoms, two N-oxide oxygen atoms, and two pyridyl nitrogen atoms. \u03c0\u2212\u03c0 interactions are observed in the crystal structure as well. However, the \u03c0\u2212\u03c0 stacking patterns of the molecular building units are different from complex <bold>3</bold>. As can be seen in Figure , a pair of Zn(PNO)<sub>2</sub>(2,2\u2032-Bipy) building units form \u03c0\u2212\u03c0 interactions through 2,2\u2032-Bipy ligands with the dihedral angle of 8.55\u00b0 and the average distance of 3.53 \u00c5. The two \u03c0\u2212\u03c0 stacked 2,2\u2032-Bipy molecules further interact with adjacent deprotonated HPNO moieties (dihedral angle: 12.68\u00b0, average distance: 3.58 \u00c5) through \u03c0\u2212\u03c0 interactions in the three-dimensional structure.</p>", "clean_text": "Crystal Structure of Zn(PNO)2(2,2'-Bipy) (4)\n\nThis complex gives a structure which is similar to that of complex 3, Figure . Zn(PNO)2(2,2'-Bipy) crystallized in the orthorhombic Pbca space group. The coordination geometry around Zn(II) is also a distorted octahedron. Zn(II) is coordinated by two hydroxyl oxygen atoms, two N-oxide oxygen atoms, and two pyridyl nitrogen atoms. \u03c0-\u03c0 interactions are observed in the crystal structure as well. However, the \u03c0-\u03c0 stacking patterns of the molecular building units are different from complex 3. As can be seen in Figure , a pair of Zn(PNO)2(2,2'-Bipy) building units form \u03c0-\u03c0 interactions through 2,2'-Bipy ligands with the dihedral angle of 8.55\u00b0 and the average distance of 3.53 \u00c5. The two \u03c0-\u03c0 stacked 2,2'-Bipy molecules further interact with adjacent deprotonated HPNO moieties (dihedral angle: 12.68\u00b0, average distance: 3.58 \u00c5) through \u03c0-\u03c0 interactions in the three-dimensional structure.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 23, "type": "text", "classification": ["else"], "content": "<p>Bond distance and angle data for complexes <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> can be seen in .</p><title>DOSY Studies of Zn(II) Coordination Complexes in Aqueous Phase</title><p>Association\u2212dissociation phenomena of coordination species in aqueous phase are important because association\u2212dissociation of a ligand from a metal center can result in changes in observed solubility and lipophilicity. In addition, investigation of association\u2212dissociation for coordination species of interest can also provide useful information to understand in vivo drug delivery mechanisms. We have previously used electrospray ionization-mass spectroscopy (ESI-MS) and diffusion-ordered NMR spectroscopy (DOSY) techniques to study mixed-ligand Cu(II) coordination species in the aqueous phase.\n</p>", "clean_text": "Bond distance and angle data for complexes 1, 3, and 4 can be seen in .\n\nDOSY Studies of Zn(II) Coordination Complexes in Aqueous Phase\n\nAssociation-dissociation phenomena of coordination species in aqueous phase are important because association-dissociation of a ligand from a metal center can result in changes in observed solubility and lipophilicity. In addition, investigation of association-dissociation for coordination species of interest can also provide useful information to understand in vivo drug delivery mechanisms. We have previously used electrospray ionization-mass spectroscopy (ESI-MS) and diffusion-ordered NMR spectroscopy (DOSY) techniques to study mixed-ligand Cu(II) coordination species in the aqueous phase. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 24, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Coordination geometry of complex <bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  Coordination geometry of complex 4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Schematic illustration of \u03c0\u2212\u03c0 interactions of complex <bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0006.tif\"></graphic>\n</fig>", "clean_text": " 6  Schematic illustration of \u03c0-\u03c0 interactions of complex 4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>DOSY spectrum of complex <bold>2</bold> in D<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0010.tif\"></graphic>\n</fig>", "clean_text": " 7  DOSY spectrum of complex 2 in D2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>DOSY spectrum of complex <bold>3</bold> in D<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0008.tif\"></graphic>\n</fig>", "clean_text": " 8  DOSY spectrum of complex 3 in D2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig id=\"fig9\" orientation=\"portrait\" position=\"float\">\n<label>9</label>\n<caption>\n<p>DOSY spectrum of complex <bold>4</bold> in D<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0009.tif\"></graphic>\n</fig>", "clean_text": " 9  DOSY spectrum of complex 4 in D2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<p>Kiss and co-workers recently characterized solution equilibrium of Zn(PNO)<sub>2</sub> in detail, and they suggested that complex <bold>1</bold> exists primarily in a dihydrate form Zn(PNO)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub> in water. In the current work, complexes <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> in water were investigated by using NMR diffusion measurement for association\u2212dissociation studies. DOSY methods are based on pulsed-field gradient spin\u2212echo NMR experiments. In particular, DOSY is effective to analyze intermediates and to discriminate different species in solution. DOSY experiments were performed on solution of complexes <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> in D<sub>2</sub>O, respectively (Figures , , and ). Two species showed up in the DOSY spectrum of complex <bold>2</bold>, as can be seen in Figure . The DOSY result of complex <bold>2</bold> clearly indicates dissociation of 3-Br-Py from Zn(II), while resulting <sup>1</sup>H DOSY spectra for complexes <bold>3</bold> and <bold>4</bold> in Figures  and  nicely suggested each mixed-ligand coordination compound exists in water as one species without observed dissociation at NMR-detectable levels. Although no further determination of the configuration of complexes <bold>3</bold> and <bold>4</bold> in water was undertaken in this study, it is clear that complexes <bold>3</bold> and <bold>4</bold> are reasonably stable in the aqueous phase from the DOSY spectra. On the basis of the DOSY results, apparently the monodentate ancillary ligand 3-Br-Py is not suitable to tune lipophilicity of Zn(PNO)<sub>2</sub> due to its poor stability in water. And it is reasonable to conclude that bidentate ancillary ligands such as 1,10-phenanthroline and 2,2\u2032-Bipy show greater affinities to Zn(II) in water and therefore are suitable to modify lipophilicity of Zn(PNO)<sub>2</sub> by forming mixed-ligand coordination species. It should be noted that the current DOSY studies of Zn(II) coordination species in aqueous phase did not intend to measure the stability constant of these complexes. In addition, such work has been performed by Kiss et al. using pH-potentiometric measurements. The DOSY studies were aimed to provide more in-depth information to interpret observed values of lipophilicities and solubilities of these Zn(II) complexes in the current work.</p>", "clean_text": "Kiss and co-workers recently characterized solution equilibrium of Zn(PNO)2 in detail, and they suggested that complex 1 exists primarily in a dihydrate form Zn(PNO)2(H2O)2 in water. In the current work, complexes 2, 3, and 4 in water were investigated by using NMR diffusion measurement for association-dissociation studies. DOSY methods are based on pulsed-field gradient spin-echo NMR experiments. In particular, DOSY is effective to analyze intermediates and to discriminate different species in solution. DOSY experiments were performed on solution of complexes 2, 3, and 4 in D2O, respectively (Figures , , and ). Two species showed up in the DOSY spectrum of complex 2, as can be seen in Figure . The DOSY result of complex 2 clearly indicates dissociation of 3-Br-Py from Zn(II), while resulting 1H DOSY spectra for complexes 3 and 4 in Figures  and  nicely suggested each mixed-ligand coordination compound exists in water as one species without observed dissociation at NMR-detectable levels. Although no further determination of the configuration of complexes 3 and 4 in water was undertaken in this study, it is clear that complexes 3 and 4 are reasonably stable in the aqueous phase from the DOSY spectra. On the basis of the DOSY results, apparently the monodentate ancillary ligand 3-Br-Py is not suitable to tune lipophilicity of Zn(PNO)2 due to its poor stability in water. And it is reasonable to conclude that bidentate ancillary ligands such as 1,10-phenanthroline and 2,2'-Bipy show greater affinities to Zn(II) in water and therefore are suitable to modify lipophilicity of Zn(PNO)2 by forming mixed-ligand coordination species. It should be noted that the current DOSY studies of Zn(II) coordination species in aqueous phase did not intend to measure the stability constant of these complexes. In addition, such work has been performed by Kiss et al. using pH-potentiometric measurements. The DOSY studies were aimed to provide more in-depth information to interpret observed values of lipophilicities and solubilities of these Zn(II) complexes in the current work.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "text", "classification": ["else"], "content": "<title>Lipophilicities and Solubilities of Zn(II) Coordination Complexes</title><p>Table  lists solubilities in water (<italic toggle=\"yes\">S</italic>\n<sub>w</sub>), octanol-saturated water (<italic toggle=\"yes\">S</italic>\n<sub>ow</sub>), and water-saturated octanol (<italic toggle=\"yes\">S</italic>\n<sub>wo</sub>) of complexes <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>. The partition coefficient (log <italic toggle=\"yes\">P</italic>) and solubility ratio, <italic toggle=\"yes\">SR</italic> (<italic toggle=\"yes\">S</italic>\n<sub>wo</sub>/<italic toggle=\"yes\">S</italic>\n<sub>ow</sub>), for each complex have also been listed in Table  and shown graphically in Figure . It is worth pointing out that log <italic toggle=\"yes\">SR</italic> has also been used as an estimate of lipophilicity to correlate with partition coefficients in some reports.\n</p>", "clean_text": "Lipophilicities and Solubilities of Zn(II) Coordination Complexes\n\nTable  lists solubilities in water (S w), octanol-saturated water (S ow), and water-saturated octanol (S wo) of complexes 1, 3, and 4. The partition coefficient (log P) and solubility ratio, SR (S wo/S ow), for each complex have also been listed in Table  and shown graphically in Figure . It is worth pointing out that log SR has also been used as an estimate of lipophilicity to correlate with partition coefficients in some reports. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 31, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Solubilities and Lipophilicities of Complexes <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"7\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col6\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col7\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">complex</oasis:entry>\n<oasis:entry align=\"center\" char=\".\">log <italic toggle=\"yes\">P</italic> of AL<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">S</italic>\n<sub>w</sub> (mg/mL)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">S</italic>\n<sub>ow</sub> (mg/mL)</oasis:entry>\n<oasis:entry align=\"center\" char=\".\">\n<italic toggle=\"yes\">S</italic>\n<sub>wo</sub> (mg/mL)</oasis:entry>\n<oasis:entry align=\"center\">log <italic toggle=\"yes\">P</italic>\n</oasis:entry>\n<oasis:entry align=\"center\">log <italic toggle=\"yes\">SR</italic>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>6.167(18)</oasis:entry>\n<oasis:entry>8.524(27)</oasis:entry>\n<oasis:entry>1.484(39)</oasis:entry>\n<oasis:entry>\u22120.8885(65)</oasis:entry>\n<oasis:entry>\u22120.7592</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry>1.751(286)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>1.780(219)</oasis:entry>\n<oasis:entry>0.4280(128)</oasis:entry>\n<oasis:entry>0.4468(96)</oasis:entry>\n<oasis:entry>0.8981(147)</oasis:entry>\n<oasis:entry>0.03909(3521)</oasis:entry>\n<oasis:entry>0.3032</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>1.284(254)</oasis:entry>\n<oasis:entry>1.775(9)</oasis:entry>\n<oasis:entry>1.869(13)</oasis:entry>\n<oasis:entry>1.373(57)</oasis:entry>\n<oasis:entry>0.5059(473)</oasis:entry>\n<oasis:entry>\u22120.1340</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Not measured due to poor stability in water.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>Log <italic toggle=\"yes\">P</italic> values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 32, "type": "figure", "classification": null, "content": "<fig id=\"fig10\" orientation=\"portrait\" position=\"float\">\n<label>10</label>\n<caption>\n<p>Log <italic toggle=\"yes\">P</italic> and log <italic toggle=\"yes\">SR</italic> values of mixed-ligand Zn(II) coordination complexes.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0007.tif\"></graphic>\n</fig>", "clean_text": " 10  Log P and log SR values of mixed-ligand Zn(II) coordination complexes.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 33, "type": "text", "classification": "error", "content": "<p>We have previously demonstrated that there is some degree of predictability in the observed lipophilicities and solubilities on the basis of the log <italic toggle=\"yes\">P</italic> of the ancillary ligand for mixed-ligand Cu(II) coordination species. Similarly, for mixed-ligand Zn coordination species of interest, log <italic toggle=\"yes\">P</italic> and log <italic toggle=\"yes\">SR</italic> values were significantly increased via the introduction of both 1,10-phenanthroline and 2,2\u2032-Bipy. Specifically, log <italic toggle=\"yes\">P</italic> values of complexes <bold>3</bold> and <bold>4</bold> were increased to 0.03909(3521) and 0.5059(473), respectively, compared to the log <italic toggle=\"yes\">P</italic> value of complex <bold>1</bold>, \u22120.8885(65). The difference in log <italic toggle=\"yes\">P</italic> is as large as 1.3944 between complex <bold>4</bold> and complex <bold>1</bold>, which indicates significant enhancement in lipophilicity by introduction of the ancillary ligand. And solubilities of mixed-ligand Zn coordination species in aqueous phase decrease with the increase of log <italic toggle=\"yes\">P</italic> values of ancillary ligands. As can be seen in Table , complex <bold>3</bold> has the lowest solubility in water and octanol saturated water with the highest log <italic toggle=\"yes\">P</italic> value of the ancillary ligand. The order of log <italic toggle=\"yes\">SR</italic> values for the mixed-ligand Zn complexes follows the order of log <italic toggle=\"yes\">P</italic> values calculated for the ancillary ligands, while the order of log <italic toggle=\"yes\">P</italic> values does not exactly reflect the order of log <italic toggle=\"yes\">P</italic> values calculated for the ancillary ligands. This could be attributed to either the uncertainty of calculated log <italic toggle=\"yes\">P</italic> values of ancillary ligands or the impact of guest water molecules in complex <bold>3</bold>.</p>", "clean_text": "We have previously demonstrated that there is some degree of predictability in the observed lipophilicities and solubilities on the basis of the log P of the ancillary ligand for mixed-ligand Cu(II) coordination species. Similarly, for mixed-ligand Zn coordination species of interest, log P and log SR values were significantly increased via the introduction of both 1,10-phenanthroline and 2,2'-Bipy. Specifically, log P values of complexes 3 and 4 were increased to 0.03909(3521) and 0.5059(473), respectively, compared to the log P value of complex 1, -0.8885(65). The difference in log P is as large as 1.3944 between complex 4 and complex 1, which indicates significant enhancement in lipophilicity by introduction of the ancillary ligand. And solubilities of mixed-ligand Zn coordination species in aqueous phase decrease with the increase of log P values of ancillary ligands. As can be seen in Table , complex 3 has the lowest solubility in water and octanol saturated water with the highest log P value of the ancillary ligand. The order of log SR values for the mixed-ligand Zn complexes follows the order of log P values calculated for the ancillary ligands, while the order of log P values does not exactly reflect the order of log P values calculated for the ancillary ligands. This could be attributed to either the uncertainty of calculated log P values of ancillary ligands or the impact of guest water molecules in complex 3.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<title>Conclusions</title><p>In the current work, the introduction of ancillary ligands to Zn(PNO)<sub>2</sub> has formed a homologous series of mixed-ligand Zn(II) coordination complexes. These mixed-ligand species are formed through coordinate bonds between the ancillary ligand and the transition metal center. We have demonstrated that there is some degree of predictability in the observed lipophilicities and solubilities of mixed-ligand Zn(II) coordination complexes on the basis of log <italic toggle=\"yes\">P</italic> of the ancillary ligand. With the introduction of a lipophilic ancillary ligand, the lipophilicity of Zn(PNO)<sub>2</sub> (with an initial negative log <italic toggle=\"yes\">P</italic> value) can be significantly increased. Interestingly, DOSY spectra suggested that association\u2212dissociation properties of mixed-ligand Zn(II) coordination complexes in aqueous phase are dependent on the coordination mode of the ancillary ligand. Unlike mixed-ligand Cu(II) coordination complexes, mixed-ligand Zn(II) coordination species composed of a monodentate ancillary ligand is unstable in water due to the weaker affinity of Zn(II) to organic ligands than Cu(II). By increasing numbers of coordination sites, mixed-ligand Zn(II) coordination species composed of a bidentate ancillary ligand exist primarily as a single species in aqueous phase as confirmed by DOSY spectra.</p>", "clean_text": "Conclusions\n\nIn the current work, the introduction of ancillary ligands to Zn(PNO)2 has formed a homologous series of mixed-ligand Zn(II) coordination complexes. These mixed-ligand species are formed through coordinate bonds between the ancillary ligand and the transition metal center. We have demonstrated that there is some degree of predictability in the observed lipophilicities and solubilities of mixed-ligand Zn(II) coordination complexes on the basis of log P of the ancillary ligand. With the introduction of a lipophilic ancillary ligand, the lipophilicity of Zn(PNO)2 (with an initial negative log P value) can be significantly increased. Interestingly, DOSY spectra suggested that association-dissociation properties of mixed-ligand Zn(II) coordination complexes in aqueous phase are dependent on the coordination mode of the ancillary ligand. Unlike mixed-ligand Cu(II) coordination complexes, mixed-ligand Zn(II) coordination species composed of a monodentate ancillary ligand is unstable in water due to the weaker affinity of Zn(II) to organic ligands than Cu(II). By increasing numbers of coordination sites, mixed-ligand Zn(II) coordination species composed of a bidentate ancillary ligand exist primarily as a single species in aqueous phase as confirmed by DOSY spectra.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 35, "type": "text", "classification": ["else"], "content": "<p>One of the anticipated concerns regarding the use of mixed-ligand Zn(II) coordination complexes could be the toxicity of ancillary ligands. The synthesized Zn(II) species presented in this study were prepared as proof-of-principle model complexes for feasibility study purposes; therefore, toxicity is not specifically addressed in the current work. In the context of mixed-ligand transition metal complexes, ancillary ligands can be either neutral or charge-compensating (i.e., anionic). In terms of the selection of ancillary ligands, we suggest \u201cgenerally recognized as safe\u201d (GRAS) substances such as acetic acid and citric acid should be considered as the first choice to form mixed-ligand coordination species. Use of some non-GRAS substances (e.g., caffeine, oxyquinoline) as ancillary ligands may follow the Food and Drug Administration (FDA) Inactive Ingredient Guide (IIG).</p>", "clean_text": "One of the anticipated concerns regarding the use of mixed-ligand Zn(II) coordination complexes could be the toxicity of ancillary ligands. The synthesized Zn(II) species presented in this study were prepared as proof-of-principle model complexes for feasibility study purposes; therefore, toxicity is not specifically addressed in the current work. In the context of mixed-ligand transition metal complexes, ancillary ligands can be either neutral or charge-compensating (i.e., anionic). In terms of the selection of ancillary ligands, we suggest \"generally recognized as safe\" (GRAS) substances such as acetic acid and citric acid should be considered as the first choice to form mixed-ligand coordination species. Use of some non-GRAS substances (e.g., caffeine, oxyquinoline) as ancillary ligands may follow the Food and Drug Administration (FDA) Inactive Ingredient Guide (IIG).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 36, "type": "text", "classification": ["else"], "content": "<p>Development of approaches to alter physical-chemical properties without covalent modifications to drug complexes, such as synthesis of pharmaceutical cocrystals and mixed-ligand coordination complexes, has become a topical area in supramolecular chemistry and crystal engineering. In this work, the data suggested the approach of forming mixed-ligand species to modify lipophilicities and solubilities of coordination complexes can be applied to a wide range of transition metal coordination systems. These results also support Thompson and Orvig\u2019s assertion - \u201cthe use of metal ions in medicine is not new. What is new is the increasing purposeful design of metal-based therapeutics.\u201d Indeed, the judicious modification to TM-based medicinal complexes with supramolecular chemistry approaches deserves greater attention and input by chemists, biochemists, and pharmacologists.</p>", "clean_text": "Development of approaches to alter physical-chemical properties without covalent modifications to drug complexes, such as synthesis of pharmaceutical cocrystals and mixed-ligand coordination complexes, has become a topical area in supramolecular chemistry and crystal engineering. In this work, the data suggested the approach of forming mixed-ligand species to modify lipophilicities and solubilities of coordination complexes can be applied to a wide range of transition metal coordination systems. These results also support Thompson and Orvig's assertion - \"the use of metal ions in medicine is not new. What is new is the increasing purposeful design of metal-based therapeutics.\" Indeed, the judicious modification to TM-based medicinal complexes with supramolecular chemistry approaches deserves greater attention and input by chemists, biochemists, and pharmacologists.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 37, "type": "text", "classification": ["else"], "content": "<p>Crystallographic data in CIF format. Bond distance and angle data for complexes <bold>1</bold>, <bold>3</bold> and <bold>4</bold>, Tables S1\u2212S3. <sup>1</sup>H chemical shift assignments for complexes <bold>2</bold>, <bold>3</bold>, and <bold>4</bold>, Table S4. This information is available free of charge via the Internet at <uri>http://pubs.acs.org</uri>.</p>", "clean_text": "Crystallographic data in CIF format. Bond distance and angle data for complexes 1, 3 and 4, Tables S1-S3. 1H chemical shift assignments for complexes 2, 3, and 4, Table S4. This information is available free of charge via the Internet at http://pubs.acs.org.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 38, "type": "text", "classification": "error", "content": "<title>References</title>", "clean_text": "References", "data": null, "include_properties": null, "intermediate_step": {"categorize": "<title>References</title>"}}], "cln_elements": [{"idx": "10, 11, 12", "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of the Complexes</title><p>Zn(PNO)<sub>2</sub> (<bold>1</bold>) was synthesized following a reported procedure, and the colorless crystal was formed. Yield: 3.97 g, 83% (100% theoretical yield is 4.78 g).</p><p>Zn(PNO)<sub>2</sub>(3-Br-Py) (<bold>2</bold>) was prepared by adding anhydrous 3-Br-Py to 0.50 g of Zn(PNO)<sub>2</sub> until the solid was merged by 3-Br-Py in a 4-mL Dram glass vial. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the white to off-white solid was collected. Yield: 0.71 g, 92%. The solid was not suitable for single crystal X-ray diffractions. The composition of complex (<bold>2</bold>) was obtained from <sup>1</sup>H NMR, \u03b4 (D<sub>2</sub>O, 400 MHz): 8.67 (1H, s), 8.49 (1H, d, <italic toggle=\"yes\">J</italic> = 4.6 Hz), 8.08 (1H, d, <italic toggle=\"yes\">J</italic> = 8.2 Hz),7.98 (2H, d, <italic toggle=\"yes\">J</italic> = 5.7 Hz) 7.49 (2H, t, <italic toggle=\"yes\">J</italic> = 6.0 Hz), 7.41 (1H, dd, <italic toggle=\"yes\">J</italic> = 4.8 Hz, <italic toggle=\"yes\">J</italic> = 7.0 Hz), 6.80 (2H, d, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 6.67 (2H, t, <italic toggle=\"yes\">J</italic> = 6.1 Hz).</p><p>[Zn(PNO)<sub>2</sub>(1,10-Phenanthroline)](H<sub>2</sub>O)<sub>5/3</sub> (<bold>3</bold>) was prepared by mixing 20 mL of Zn(PNO)<sub>2</sub> water solution (5.71 g/L) and 4 mL of 1,10-phenanthroline EtOH solution (18.0 g/L) in a flask. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the colorless crystal was formed. Yield: 0.10 g, 51%. The composition of complex (<bold>3</bold>) was also confirmed by <sup>1</sup>H NMR, \u03b4 (D<sub>2</sub>O, 400 MHz): 8.98 (2H, d, <italic toggle=\"yes\">J</italic> = 4.3 Hz), 8.66 (2H, d, <italic toggle=\"yes\">J</italic> = 8.0 Hz), 8.07 (2H, s), 7.96 (2H, d, <italic toggle=\"yes\">J</italic> = 6.2 Hz), 7.90 (2H, t, <italic toggle=\"yes\">J</italic> = 2.1 Hz), 7.37 (2H, t, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 6.68 (2H, d, <italic toggle=\"yes\">J</italic> = 8.6 Hz), 6.53 (2H, t, <italic toggle=\"yes\">J</italic> = 7.0 Hz).</p><p>Zn(PNO)<sub>2</sub>(2,2\u2032-Bipy) (<bold>4</bold>) was synthesized under hydrothermal conditions: 15 mL of Zn(PNO)<sub>2</sub> water solution (5.71 g/L) was placed into a 20 mL Teflon autoclave, and 0.3 mmol of 2,2-Bipy was then transferred into the autoclave as well. The Teflon autoclave was then sealed and placed in an oven with holding the temperature at 130 \u00b0C overnight. And the oven was turned off to allow the Teflon bomb to cool down gradually. The colorless crystal was formed. Yield: 0.065 g, 49%. The composition of complex (<bold>4</bold>) was also confirmed by <sup>1</sup>H NMR, \u03b4 (D<sub>2</sub>O, 400 MHz): 8.59 (2H, s), 8.37 (2H, d, <italic toggle=\"yes\">J</italic> = 8.0 Hz), 8.12 (2H, d, <italic toggle=\"yes\">J</italic> = 7.8 Hz), 7.82 (2H, d, <italic toggle=\"yes\">J</italic> = 6.2 Hz), 7.58 (2H, t, <italic toggle=\"yes\">J</italic> = 5.9 Hz), 7.36 (2H, t, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 6.68 (2H, d, <italic toggle=\"yes\">J</italic> = 7.9 Hz), 6.53 (2H, t, <italic toggle=\"yes\">J</italic> = 6.7 Hz).</p>", "clean_text": "Synthesis of the Complexes\n\nZn(PNO)2 (1) was synthesized following a reported procedure, and the colorless crystal was formed. Yield: 3.97 g, 83% (100% theoretical yield is 4.78 g).\n\nZn(PNO)2(3-Br-Py) (2) was prepared by adding anhydrous 3-Br-Py to 0.50 g of Zn(PNO)2 until the solid was merged by 3-Br-Py in a 4-mL Dram glass vial. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the white to off-white solid was collected. Yield: 0.71 g, 92%. The solid was not suitable for single crystal X-ray diffractions. The composition of complex (2) was obtained from 1H NMR, \u03b4 (D2O, 400 MHz): 8.67 (1H, s), 8.49 (1H, d, J = 4.6 Hz), 8.08 (1H, d, J = 8.2 Hz),7.98 (2H, d, J = 5.7 Hz) 7.49 (2H, t, J = 6.0 Hz), 7.41 (1H, dd, J = 4.8 Hz, J = 7.0 Hz), 6.80 (2H, d, J = 8.4 Hz), 6.67 (2H, t, J = 6.1 Hz).\n\n[Zn(PNO)2(1,10-Phenanthroline)](H2O)5/3 (3) was prepared by mixing 20 mL of Zn(PNO)2 water solution (5.71 g/L) and 4 mL of 1,10-phenanthroline EtOH solution (18.0 g/L) in a flask. The mixture was placed in a water bath at 60 \u00b0C for 1 h and then set aside. After one day, the colorless crystal was formed. Yield: 0.10 g, 51%. The composition of complex (3) was also confirmed by 1H NMR, \u03b4 (D2O, 400 MHz): 8.98 (2H, d, J = 4.3 Hz), 8.66 (2H, d, J = 8.0 Hz), 8.07 (2H, s), 7.96 (2H, d, J = 6.2 Hz), 7.90 (2H, t, J = 2.1 Hz), 7.37 (2H, t, J = 7.7 Hz), 6.68 (2H, d, J = 8.6 Hz), 6.53 (2H, t, J = 7.0 Hz).\n\nZn(PNO)2(2,2'-Bipy) (4) was synthesized under hydrothermal conditions: 15 mL of Zn(PNO)2 water solution (5.71 g/L) was placed into a 20 mL Teflon autoclave, and 0.3 mmol of 2,2-Bipy was then transferred into the autoclave as well. The Teflon autoclave was then sealed and placed in an oven with holding the temperature at 130 \u00b0C overnight. And the oven was turned off to allow the Teflon bomb to cool down gradually. The colorless crystal was formed. Yield: 0.065 g, 49%. The composition of complex (4) was also confirmed by 1H NMR, \u03b4 (D2O, 400 MHz): 8.59 (2H, s), 8.37 (2H, d, J = 8.0 Hz), 8.12 (2H, d, J = 7.8 Hz), 7.82 (2H, d, J = 6.2 Hz), 7.58 (2H, t, J = 5.9 Hz), 7.36 (2H, t, J = 7.7 Hz), 6.68 (2H, d, J = 7.9 Hz), 6.53 (2H, t, J = 6.7 Hz).", "data": [[{"meta": {"name": "Zn(PNO)2", "symbol": "1", "chemical formula": ""}, "processes": [{"synthesis method": "reported procedure", "information": "colorless crystal"}], "yield": "83%", "other properties": []}, {"meta": {"name": "Zn(PNO)2(3-Br-Py)", "symbol": "2", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "Zn(PNO)2", "amount": "0.50", "unit": "g"}, {"name": "3-Br-Py", "amount": "", "unit": ""}], "solution": [], "pressure": "", "temperature": "60 \u00b0C", "time": "1 h"}], "yield": "92%", "other properties": ["1H NMR"]}, {"meta": {"name": "[Zn(PNO)2(1,10-Phenanthroline)](H2O)5/3", "symbol": "3", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "Zn(PNO)2 water solution", "amount": "20", "unit": "mL"}, {"name": "1,10-phenanthroline EtOH solution", "amount": "4", "unit": "mL"}], "solution": [], "pressure": "", "temperature": "60 \u00b0C", "time": "1 h"}], "yield": "51%", "other properties": ["1H NMR"]}, {"meta": {"name": "Zn(PNO)2(2,2'-Bipy)", "symbol": "4", "chemical formula": ""}, "processes": [{"synthesis method": "hydrothermal synthesis", "precursor": [{"name": "Zn(PNO)2 water solution", "amount": "15", "unit": "mL"}, {"name": "2,2'-Bipy", "amount": "0.3", "unit": "mmol"}], "solvent": [], "reducing agent": [], "surfactant": [], "pressure": "", "temperature": "130 \u00b0C", "time": "overnight", "heating rate": "", "cooling rate": "gradual"}], "yield": "49%", "other properties": ["1H NMR"]}]], "include_properties": ["solvothermal_synthesis", "chemical_synthesis"], "intermediate_step": {"text-synthesis-type": "['chemical_synthesis', 'chemical_synthesis', 'chemical_synthesis', 'solvothermal_synthesis']", "text-synthesis-struct": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Zn(PNO)2\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"reported procedure\",\n                \"information\": \"colorless crystal\"\n            }\n        ],\n        \"yield\": \"83%\",\n        \"other properties\": []\n    },\n    {\n        \"meta\": {\n            \"name\": \"Zn(PNO)2(3-Br-Py)\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Zn(PNO)2\",\n                        \"amount\": \"0.50\",\n                        \"unit\": \"g\"\n                    },\n                    {\n                        \"name\": \"3-Br-Py\",\n                        \"amount\": \"\",\n                        \"unit\": \"\"\n                    }\n                ],\n                \"solution\": [],\n                \"pressure\": \"\",\n                \"temperature\": \"60 \u00b0C\",\n                \"time\": \"1 h\"\n            }\n        ],\n        \"yield\": \"92%\",\n        \"other properties\": [\"1H NMR\"]\n    },\n    {\n        \"meta\": {\n            \"name\": \"[Zn(PNO)2(1,10-Phenanthroline)](H2O)5/3\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"chemical synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Zn(PNO)2 water solution\",\n                        \"amount\": \"20\",\n                        \"unit\": \"mL\"\n                    },\n                    {\n                        \"name\": \"1,10-phenanthroline EtOH solution\",\n                        \"amount\": \"4\",\n                        \"unit\": \"mL\"\n                    }\n                ],\n                \"solution\": [],\n                \"pressure\": \"\",\n                \"temperature\": \"60 \u00b0C\",\n                \"time\": \"1 h\"\n            }\n        ],\n        \"yield\": \"51%\",\n        \"other properties\": [\"1H NMR\"]\n    },\n    {\n        \"meta\": {\n            \"name\": \"Zn(PNO)2(2,2'-Bipy)\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"\"\n        },\n        \"processes\": [\n            {\n                \"synthesis method\": \"hydrothermal synthesis\",\n                \"precursor\": [\n                    {\n                        \"name\": \"Zn(PNO)2 water solution\",\n                        \"amount\": \"15\",\n                        \"unit\": \"mL\"\n                    },\n                    {\n                        \"name\": \"2,2'-Bipy\",\n                        \"amount\": \"0.3\",\n                        \"unit\": \"mmol\"\n                    }\n                ],\n                \"solvent\": [],\n                \"reducing agent\": [],\n                \"surfactant\": [],\n                \"pressure\": \"\",\n                \"temperature\": \"130 \u00b0C\",\n                \"time\": \"overnight\",\n                \"heating rate\": \"\",\n                \"cooling rate\": \"gradual\"\n            }\n        ],\n        \"yield\": \"49%\",\n        \"other properties\": [\"1H NMR\"]\n    }\n]\n```"}}, {"idx": 18, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data and Structure Refinement Details for <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry>compound</oasis:entry>\n<oasis:entry>complex <bold>1</bold>\n</oasis:entry>\n<oasis:entry>complex <bold>3</bold>\n</oasis:entry>\n<oasis:entry>complex <bold>4</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>10</sub>H<sub>8</sub>N<sub>2</sub>O<sub>4</sub>Zn</oasis:entry>\n<oasis:entry>C<sub>66</sub>H<sub>58</sub>N<sub>12</sub>O<sub>17</sub>Zn<sub>3</sub>\n</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>Zn</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>color</oasis:entry>\n<oasis:entry>colorless</oasis:entry>\n<oasis:entry>colorless</oasis:entry>\n<oasis:entry>colorless</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size (mm)</oasis:entry>\n<oasis:entry>0.90 \u00d7 0.85 \u00d7 0.80</oasis:entry>\n<oasis:entry>0.50 \u00d7 0.20 \u00d7 0.10</oasis:entry>\n<oasis:entry>0.50 \u00d7 0.40 \u00d7 0.40</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>formula weight</oasis:entry>\n<oasis:entry>285.55</oasis:entry>\n<oasis:entry>1487.35</oasis:entry>\n<oasis:entry>441.74</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>temperature (K)</oasis:entry>\n<oasis:entry>90(2)</oasis:entry>\n<oasis:entry>90(2)</oasis:entry>\n<oasis:entry>90(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>wavelength (\u00c5)</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal system, space group</oasis:entry>\n<oasis:entry>triclinic, <italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>triclinic, <italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>orthorhombic, <italic toggle=\"yes\">Pbca</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>6.343(9)</oasis:entry>\n<oasis:entry>9.1837(18)</oasis:entry>\n<oasis:entry>9.5912(19)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>8.856(13)</oasis:entry>\n<oasis:entry>18.715(4)</oasis:entry>\n<oasis:entry>15.983(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.599(14)</oasis:entry>\n<oasis:entry>19.053(4)</oasis:entry>\n<oasis:entry>24.334(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (\u00b0)</oasis:entry>\n<oasis:entry>81.49(2)</oasis:entry>\n<oasis:entry>105.34(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (\u00b0)</oasis:entry>\n<oasis:entry>79.87(2)</oasis:entry>\n<oasis:entry>94.59(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (\u00b0)</oasis:entry>\n<oasis:entry>81.30(2)</oasis:entry>\n<oasis:entry>98.05(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>volume (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>520.7(13)</oasis:entry>\n<oasis:entry>3103.3(11)</oasis:entry>\n<oasis:entry>3730.4(13)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Z<italic toggle=\"yes\">,</italic> calculated density (mg/cm<sup>3</sup>)</oasis:entry>\n<oasis:entry>2, 1.821</oasis:entry>\n<oasis:entry>2, 1.592</oasis:entry>\n<oasis:entry>8, 1.573</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>absorption coefficient (mm<sup>\u22121</sup>)</oasis:entry>\n<oasis:entry>2.362</oasis:entry>\n<oasis:entry>1.235</oasis:entry>\n<oasis:entry>1.353</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">F</italic>(000)</oasis:entry>\n<oasis:entry>288</oasis:entry>\n<oasis:entry>1528</oasis:entry>\n<oasis:entry>1808</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>reflections collected/unique</oasis:entry>\n<oasis:entry>3331/1949 [R(int) = 0.1570]</oasis:entry>\n<oasis:entry>10726/9733 [R(int) = 0.0702]</oasis:entry>\n<oasis:entry>18301/3474 [R(int) = 0.0290]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>completeness to \u03b8 = <italic toggle=\"yes\">x</italic>\u00b0 (%)</oasis:entry>\n<oasis:entry>95.1 (theta = 26.02)</oasis:entry>\n<oasis:entry>89.1 (theta = 25.00)</oasis:entry>\n<oasis:entry>100.0 (theta = 25.50)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>max and min transmission</oasis:entry>\n<oasis:entry>0.2538 and 0.2250</oasis:entry>\n<oasis:entry>0.8865 and 0.5772</oasis:entry>\n<oasis:entry>0.6137 and 0.5511</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>refinement method</oasis:entry>\n<oasis:entry>full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>full-matrix least-squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>goodness-of-fit on <italic toggle=\"yes\">F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.078</oasis:entry>\n<oasis:entry>1.036</oasis:entry>\n<oasis:entry>1.053</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>final <italic toggle=\"yes\">R</italic> indices [<italic toggle=\"yes\">I</italic> &gt; 2\u03c3(I)]</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0698, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.1883</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0791, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.1845</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0270, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.0735</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic> indices (all data)</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0795, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.2008</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.1210, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.2014</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = 0.0308, <italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = 0.0756</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>CCDC number</oasis:entry>\n<oasis:entry>749773</oasis:entry>\n<oasis:entry>749774</oasis:entry>\n<oasis:entry>749775</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 1. Crystallographic Data and Structure Refinement Details for 1, 3, and 4\n\n| compound | complex 1 | complex 3 | complex 4 |\n|----------|-----------|-----------|-----------|\n| empirical formula | C<sub>10</sub>H<sub>8</sub>N<sub>2</sub>O<sub>4</sub>Zn | C<sub>66</sub>H<sub>58</sub>N<sub>12</sub>O<sub>17</sub>Zn<sub>3</sub> | C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>Zn |\n| color | colorless | colorless | colorless |\n| crystal size (mm) | 0.90 \u00d7 0.85 \u00d7 0.80 | 0.50 \u00d7 0.20 \u00d7 0.10 | 0.50 \u00d7 0.40 \u00d7 0.40 |\n| formula weight | 285.55 | 1487.35 | 441.74 |\n| temperature (K) | 90(2) | 90(2) | 90(2) |\n| wavelength (\u00c5) | 0.71073 | 0.71073 | 0.71073 |\n| crystal system, space group | triclinic, *P*1\u0305 | triclinic, *P*1\u0305 | orthorhombic, *Pbca* |\n| *a* (\u00c5) | 6.343(9) | 9.1837(18) | 9.5912(19) |\n| *b* (\u00c5) | 8.856(13) | 18.715(4) | 15.983(3) |\n| *c* (\u00c5) | 9.599(14) | 19.053(4) | 24.334(5) |\n| *\u03b1* (\u00b0) | 81.49(2) | 105.34(3) | 90 |\n| *\u03b2* (\u00b0) | 79.87(2) | 94.59(3) | 90 |\n| *\u03b3* (\u00b0) | 81.30(2) | 98.05(3) | 90 |\n| volume (\u00c5<sup>3</sup>) | 520.7(13) | 3103.3(11) | 3730.4(13) |\n| *Z*, calculated density (mg/cm<sup>3</sup>) | 2, 1.821 | 2, 1.592 | 8, 1.573 |\n| absorption coefficient (mm<sup>\u22121</sup>) | 2.362 | 1.235 | 1.353 |\n| *F*(000) | 288 | 1528 | 1808 |\n| reflections collected/unique | 3331/1949 [R(int) = 0.1570] | 10726/9733 [R(int) = 0.0702] | 18301/3474 [R(int) = 0.0290] |\n| completeness to \u03b8 = *x*\u00b0 (%) | 95.1 (theta = 26.02) | 89.1 (theta = 25.00) | 100.0 (theta = 25.50) |\n| max and min transmission | 0.2538 and 0.2250 | 0.8865 and 0.5772 | 0.6137 and 0.5511 |\n| refinement method | full-matrix least-squares on *F*<sup>2</sup> | full-matrix least-squares on *F*<sup>2</sup> | full-matrix least-squares on *F*<sup>2</sup> |\n| goodness-of-fit on *F*<sup>2</sup> | 1.078 | 1.036 | 1.053 |\n| final *R* indices [*I* > 2\u03c3(*I*)] | *R*<sub>1</sub> = 0.0698, *wR*<sub>2</sub> = 0.1883 | *R*<sub>1</sub> = 0.0791, *wR*<sub>2</sub> = 0.1845 | *R*<sub>1</sub> = 0.0270, *wR*<sub>2</sub> = 0.0735 |\n| *R* indices (all data) | *R*<sub>1</sub> = 0.0795, *wR*<sub>2</sub> = 0.2008 | *R*<sub>1</sub> = 0.1210, *wR*<sub>2</sub> = 0.2014 | *R*<sub>1</sub> = 0.0308, *wR*<sub>2</sub> = 0.0756 |\n| CCDC number | 749773 | 749774 | 749775 |", "data": [[{"meta": {"name": "", "symbol": "complex 1", "chemical formula": "C10H8N2O4Zn"}, "chemical formula weight": [{"value": "285.55", "unit": "", "condition": ""}], "crystal size": [{"value": "0.90 x 0.85 x 0.80", "unit": "mm", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "6.343(9)", "b": "8.856(13)", "c": "9.599(14)", "alpha": "81.49(2)", "beta": "79.87(2)", "gamma": "81.30(2)"}, "condition": ""}], "cell volume": [{"value": "520.7(13)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.821", "unit": "mg/cm^3", "condition": ""}], "material color": [{"value": "colorless", "condition": ""}]}, {"meta": {"name": "", "symbol": "complex 3", "chemical formula": "C66H58N12O17Zn3"}, "chemical formula weight": [{"value": "1487.35", "unit": "", "condition": ""}], "crystal size": [{"value": "0.50 x 0.20 x 0.10", "unit": "mm", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "9.1837(18)", "b": "18.715(4)", "c": "19.053(4)", "alpha": "105.34(3)", "beta": "94.59(3)", "gamma": "98.05(3)"}, "condition": ""}], "cell volume": [{"value": "3103.3(11)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.592", "unit": "mg/cm^3", "condition": ""}], "material color": [{"value": "colorless", "condition": ""}]}, {"meta": {"name": "", "symbol": "complex 4", "chemical formula": "C20H16N4O4Zn"}, "chemical formula weight": [{"value": "441.74", "unit": "", "condition": ""}], "crystal size": [{"value": "0.50 x 0.40 x 0.40", "unit": "mm", "condition": ""}], "crystal system": [{"value": "orthorhombic", "condition": ""}], "space group": [{"value": "Pbca", "condition": ""}], "lattice parameters": [{"value": {"a": "9.5912(19)", "b": "15.983(3)", "c": "24.334(5)", "alpha": "90", "beta": "90", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "3730.4(13)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.573", "unit": "mg/cm^3", "condition": ""}], "material color": [{"value": "colorless", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "crystal_size", "crystal_system", "space_group", "lattice_parameters", "cell_volume", "density", "material_color"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Crystallographic Data and Structure Refinement Details for 1, 3, and 4\n\n| compound | complex 1 | complex 3 | complex 4 |\n|----------|-----------|-----------|-----------|\n| empirical formula | C<sub>10</sub>H<sub>8</sub>N<sub>2</sub>O<sub>4</sub>Zn | C<sub>66</sub>H<sub>58</sub>N<sub>12</sub>O<sub>17</sub>Zn<sub>3</sub> | C<sub>20</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>Zn |\n| color | colorless | colorless | colorless |\n| crystal size (mm) | 0.90 \u00d7 0.85 \u00d7 0.80 | 0.50 \u00d7 0.20 \u00d7 0.10 | 0.50 \u00d7 0.40 \u00d7 0.40 |\n| formula weight | 285.55 | 1487.35 | 441.74 |\n| temperature (K) | 90(2) | 90(2) | 90(2) |\n| wavelength (\u00c5) | 0.71073 | 0.71073 | 0.71073 |\n| crystal system, space group | triclinic, *P*1\u0305 | triclinic, *P*1\u0305 | orthorhombic, *Pbca* |\n| *a* (\u00c5) | 6.343(9) | 9.1837(18) | 9.5912(19) |\n| *b* (\u00c5) | 8.856(13) | 18.715(4) | 15.983(3) |\n| *c* (\u00c5) | 9.599(14) | 19.053(4) | 24.334(5) |\n| *\u03b1* (\u00b0) | 81.49(2) | 105.34(3) | 90 |\n| *\u03b2* (\u00b0) | 79.87(2) | 94.59(3) | 90 |\n| *\u03b3* (\u00b0) | 81.30(2) | 98.05(3) | 90 |\n| volume (\u00c5<sup>3</sup>) | 520.7(13) | 3103.3(11) | 3730.4(13) |\n| *Z*, calculated density (mg/cm<sup>3</sup>) | 2, 1.821 | 2, 1.592 | 8, 1.573 |\n| absorption coefficient (mm<sup>\u22121</sup>) | 2.362 | 1.235 | 1.353 |\n| *F*(000) | 288 | 1528 | 1808 |\n| reflections collected/unique | 3331/1949 [R(int) = 0.1570] | 10726/9733 [R(int) = 0.0702] | 18301/3474 [R(int) = 0.0290] |\n| completeness to \u03b8 = *x*\u00b0 (%) | 95.1 (theta = 26.02) | 89.1 (theta = 25.00) | 100.0 (theta = 25.50) |\n| max and min transmission | 0.2538 and 0.2250 | 0.8865 and 0.5772 | 0.6137 and 0.5511 |\n| refinement method | full-matrix least-squares on *F*<sup>2</sup> | full-matrix least-squares on *F*<sup>2</sup> | full-matrix least-squares on *F*<sup>2</sup> |\n| goodness-of-fit on *F*<sup>2</sup> | 1.078 | 1.036 | 1.053 |\n| final *R* indices [*I* > 2\u03c3(*I*)] | *R*<sub>1</sub> = 0.0698, *wR*<sub>2</sub> = 0.1883 | *R*<sub>1</sub> = 0.0791, *wR*<sub>2</sub> = 0.1845 | *R*<sub>1</sub> = 0.0270, *wR*<sub>2</sub> = 0.0735 |\n| *R* indices (all data) | *R*<sub>1</sub> = 0.0795, *wR*<sub>2</sub> = 0.2008 | *R*<sub>1</sub> = 0.1210, *wR*<sub>2</sub> = 0.2014 | *R*<sub>1</sub> = 0.0308, *wR*<sub>2</sub> = 0.0756 |\n| CCDC number | 749773 | 749774 | 749775 |\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"complex 1\",\n            \"chemical formula\": \"C10H8N2O4Zn\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"285.55\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.90 x 0.85 x 0.80\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"6.343(9)\",\n                    \"b\": \"8.856(13)\",\n                    \"c\": \"9.599(14)\",\n                    \"alpha\": \"81.49(2)\",\n                    \"beta\": \"79.87(2)\",\n                    \"gamma\": \"81.30(2)\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"520.7(13)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.821\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"material color\": [\n            {\n                \"value\": \"colorless\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"complex 3\",\n            \"chemical formula\": \"C66H58N12O17Zn3\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"1487.35\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.50 x 0.20 x 0.10\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.1837(18)\",\n                    \"b\": \"18.715(4)\",\n                    \"c\": \"19.053(4)\",\n                    \"alpha\": \"105.34(3)\",\n                    \"beta\": \"94.59(3)\",\n                    \"gamma\": \"98.05(3)\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"3103.3(11)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.592\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"material color\": [\n            {\n                \"value\": \"colorless\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"complex 4\",\n            \"chemical formula\": \"C20H16N4O4Zn\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"441.74\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.50 x 0.40 x 0.40\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"orthorhombic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"Pbca\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.5912(19)\",\n                    \"b\": \"15.983(3)\",\n                    \"c\": \"24.334(5)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"90\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"3730.4(13)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.573\",\n                \"unit\": \"mg/cm^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"material color\": [\n            {\n                \"value\": \"colorless\",\n                \"condition\": \"\",\n            }\n        ],\n    }\n]\n```"}}, {"idx": 31, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Solubilities and Lipophilicities of Complexes <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"7\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col6\"></oasis:colspec>\n<oasis:colspec align=\"char\" char=\".\" colname=\"col7\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">complex</oasis:entry>\n<oasis:entry align=\"center\" char=\".\">log <italic toggle=\"yes\">P</italic> of AL<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">S</italic>\n<sub>w</sub> (mg/mL)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">S</italic>\n<sub>ow</sub> (mg/mL)</oasis:entry>\n<oasis:entry align=\"center\" char=\".\">\n<italic toggle=\"yes\">S</italic>\n<sub>wo</sub> (mg/mL)</oasis:entry>\n<oasis:entry align=\"center\">log <italic toggle=\"yes\">P</italic>\n</oasis:entry>\n<oasis:entry align=\"center\">log <italic toggle=\"yes\">SR</italic>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>6.167(18)</oasis:entry>\n<oasis:entry>8.524(27)</oasis:entry>\n<oasis:entry>1.484(39)</oasis:entry>\n<oasis:entry>\u22120.8885(65)</oasis:entry>\n<oasis:entry>\u22120.7592</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry>1.751(286)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>1.780(219)</oasis:entry>\n<oasis:entry>0.4280(128)</oasis:entry>\n<oasis:entry>0.4468(96)</oasis:entry>\n<oasis:entry>0.8981(147)</oasis:entry>\n<oasis:entry>0.03909(3521)</oasis:entry>\n<oasis:entry>0.3032</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>1.284(254)</oasis:entry>\n<oasis:entry>1.775(9)</oasis:entry>\n<oasis:entry>1.869(13)</oasis:entry>\n<oasis:entry>1.373(57)</oasis:entry>\n<oasis:entry>0.5059(473)</oasis:entry>\n<oasis:entry>\u22120.1340</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Not measured due to poor stability in water.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>Log <italic toggle=\"yes\">P</italic> values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. Solubilities and Lipophilicities of Complexes 1, 3, and 4\n\n| complex | log P of AL[^b] | S<sub>w</sub> (mg/mL) | S<sub>ow</sub> (mg/mL) | S<sub>wo</sub> (mg/mL) | log P | log SR |\n|---------|----------------|----------------------|-----------------------|-----------------------|-------|--------|\n| 1       |                | 6.167(18)            | 8.524(27)             | 1.484(39)             | \u22120.8885(65) | \u22120.7592 |\n| 2[^a]   | 1.751(286)     |                      |                       |                       |       |        |\n| 3       | 1.780(219)     | 0.4280(128)          | 0.4468(96)            | 0.8981(147)           | 0.03909(3521) | 0.3032 |\n| 4       | 1.284(254)     | 1.775(9)             | 1.869(13)             | 1.373(57)             | 0.5059(473) | \u22120.1340 |\n\n[^a]: Not measured due to poor stability in water.\n[^b]: Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.", "data": [[{"meta": {"name": "1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "S<sub>w</sub>", "value": "6.167(18)", "unit": "mg/mL", "condition": ""}, {"property name": "S<sub>ow</sub>", "value": "8.524(27)", "unit": "mg/mL", "condition": ""}, {"property name": "S<sub>wo</sub>", "value": "1.484(39)", "unit": "mg/mL", "condition": ""}, {"property name": "log P", "value": "\u22120.8885(65)", "unit": "", "condition": ""}, {"property name": "log SR", "value": "\u22120.7592", "unit": "", "condition": ""}]}, {"meta": {"name": "2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "log P of AL", "value": "1.751(286)", "unit": "", "condition": "Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris."}, {"property name": "Note", "value": "Not measured due to poor stability in water.", "unit": "", "condition": ""}]}, {"meta": {"name": "3", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "log P of AL", "value": "1.780(219)", "unit": "", "condition": "Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris."}, {"property name": "S<sub>w</sub>", "value": "0.4280(128)", "unit": "mg/mL", "condition": ""}, {"property name": "S<sub>ow</sub>", "value": "0.4468(96)", "unit": "mg/mL", "condition": ""}, {"property name": "S<sub>wo</sub>", "value": "0.8981(147)", "unit": "mg/mL", "condition": ""}, {"property name": "log P", "value": "0.03909(3521)", "unit": "", "condition": ""}, {"property name": "log SR", "value": "0.3032", "unit": "", "condition": ""}]}, {"meta": {"name": "4", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "log P of AL", "value": "1.284(254)", "unit": "", "condition": "Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris."}, {"property name": "S<sub>w</sub>", "value": "1.775(9)", "unit": "mg/mL", "condition": ""}, {"property name": "S<sub>ow</sub>", "value": "1.869(13)", "unit": "mg/mL", "condition": ""}, {"property name": "S<sub>wo</sub>", "value": "1.373(57)", "unit": "mg/mL", "condition": ""}, {"property name": "log P", "value": "0.5059(473)", "unit": "", "condition": ""}, {"property name": "log SR", "value": "\u22120.1340", "unit": "", "condition": ""}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 2. Solubilities and Lipophilicities of Complexes 1, 3, and 4\n\n| complex | log P of AL[^b] | S<sub>w</sub> (mg/mL) | S<sub>ow</sub> (mg/mL) | S<sub>wo</sub> (mg/mL) | log P | log SR |\n|---------|----------------|----------------------|-----------------------|-----------------------|-------|--------|\n| 1       |                | 6.167(18)            | 8.524(27)             | 1.484(39)             | \u22120.8885(65) | \u22120.7592 |\n| 2[^a]   | 1.751(286)     |                      |                       |                       |       |        |\n| 3       | 1.780(219)     | 0.4280(128)          | 0.4468(96)            | 0.8981(147)           | 0.03909(3521) | 0.3032 |\n| 4       | 1.284(254)     | 1.775(9)             | 1.869(13)             | 1.373(57)             | 0.5059(473) | \u22120.1340 |\n\n[^a]: Not measured due to poor stability in water.\n[^b]: Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"S<sub>w</sub>\",\n                \"value\": \"6.167(18)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"S<sub>ow</sub>\",\n                \"value\": \"8.524(27)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"S<sub>wo</sub>\",\n                \"value\": \"1.484(39)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"log P\",\n                \"value\": \"\u22120.8885(65)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"log SR\",\n                \"value\": \"\u22120.7592\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"log P of AL\",\n                \"value\": \"1.751(286)\",\n                \"unit\": \"\",\n                \"condition\": \"Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.\",\n            },\n            {\n                \"property name\": \"Note\",\n                \"value\": \"Not measured due to poor stability in water.\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"3\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"log P of AL\",\n                \"value\": \"1.780(219)\",\n                \"unit\": \"\",\n                \"condition\": \"Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.\",\n            },\n            {\n                \"property name\": \"S<sub>w</sub>\",\n                \"value\": \"0.4280(128)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"S<sub>ow</sub>\",\n                \"value\": \"0.4468(96)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"S<sub>wo</sub>\",\n                \"value\": \"0.8981(147)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"log P\",\n                \"value\": \"0.03909(3521)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"log SR\",\n                \"value\": \"0.3032\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"4\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"log P of AL\",\n                \"value\": \"1.284(254)\",\n                \"unit\": \"\",\n                \"condition\": \"Log P values of ancillary ligands were calculated using Advanced Chemistry Development (ACD/Laboratories) software, version 8.14, for Solaris.\",\n            },\n            {\n                \"property name\": \"S<sub>w</sub>\",\n                \"value\": \"1.775(9)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"S<sub>ow</sub>\",\n                \"value\": \"1.869(13)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"S<sub>wo</sub>\",\n                \"value\": \"1.373(57)\",\n                \"unit\": \"mg/mL\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"log P\",\n                \"value\": \"0.5059(473)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"log SR\",\n                \"value\": \"\u22120.1340\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            }\n        ],\n    }\n]\n```"}}, {"idx": 16, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Coordination geometry of complex <bold>1</bold>.</p>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Coordination geometry of complex 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>One-dimensional chain structure in complex <bold>1</bold>.</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  One-dimensional chain structure in complex 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Coordination geometry of complex <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Coordination geometry of complex 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Schematic illustration of \u03c0\u2212\u03c0 interactions in complex <bold>3</bold>.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  Schematic illustration of \u03c0-\u03c0 interactions in complex 3.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Coordination geometry of complex <bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  Coordination geometry of complex 4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Schematic illustration of \u03c0\u2212\u03c0 interactions of complex <bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0006.tif\"></graphic>\n</fig>", "clean_text": " 6  Schematic illustration of \u03c0-\u03c0 interactions of complex 4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>DOSY spectrum of complex <bold>2</bold> in D<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0010.tif\"></graphic>\n</fig>", "clean_text": " 7  DOSY spectrum of complex 2 in D2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>DOSY spectrum of complex <bold>3</bold> in D<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0008.tif\"></graphic>\n</fig>", "clean_text": " 8  DOSY spectrum of complex 3 in D2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 28, "type": "figure", "classification": null, "content": "<fig id=\"fig9\" orientation=\"portrait\" position=\"float\">\n<label>9</label>\n<caption>\n<p>DOSY spectrum of complex <bold>4</bold> in D<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0009.tif\"></graphic>\n</fig>", "clean_text": " 9  DOSY spectrum of complex 4 in D2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 32, "type": "figure", "classification": null, "content": "<fig id=\"fig10\" orientation=\"portrait\" position=\"float\">\n<label>10</label>\n<caption>\n<p>Log <italic toggle=\"yes\">P</italic> and log <italic toggle=\"yes\">SR</italic> values of mixed-ligand Zn(II) coordination complexes.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"cg-2010-00192z_0007.tif\"></graphic>\n</fig>", "clean_text": " 10  Log P and log SR values of mixed-ligand Zn(II) coordination complexes.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/cg100192z", "title": "\nModifying Lipophilicities of Zn(II) Coordination Species by Introduction of Ancillary Ligands: A Supramolecular Chemistry Approach\n", "journal": "American Chemical Society", "date": "2010.04", "author_list": ["Ma\nZhenbo", "Hopson\nRussell", "Cai\nChen", "Han\nShuangbing", "Moulton\nBrian"]}}